DUBLIN, May 14, 2020 /PRNewswire/ -- The "Global Regenerative Medicine Market By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Others), By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Regenerative Medicine Market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function. They are also being used to create solutions for organs that become permanently damaged. These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.

Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for the regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The Global Regenerative Medicine Market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region. The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others. Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases.

Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical. The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.

Major players operating in the Global Regenerative Medicine Market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:

Objective of the Study

Key Topics Covered

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Regenerative Medicine Market

4. Executive Summary

5. Voice of Customer

6. Global Regenerative Medicine Market Outlook6.1. Market Size & Forecast6.1.1. By Value & Volume6.2. Market Share & Forecast6.2.1. By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Tissue-Engineering, Immunomodulation therapy, Blood transfusion, Bone marrow transplantation, Plasma rich plasma therapy, Prolotherapy, Others)6.2.2. By Application (Musculoskeletal Disorders, Wound Care, Oncology, Neurology, Ocular Disorders, Diabetes, Cardiology, Others)6.2.3. By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical)6.2.3.1. By Synthetic Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Materials)6.2.3.2. By Biologically Derived Material (Collagen, Xenogeneic Material)6.2.3.3. By Genetically Engineered Material (Genetically Manipulated Cells, 3D Polymer Technology, Transgenic, Fibroblast, Neural Stem Cells, Gene-activated Matrices)6.2.3.4. By Pharmaceutical (Small Molecules, Biologics)6.2.4. By Cell (Autologous, Allogenic)6.2.5. By Product (Biologic, Cell -based Medical Devices, Biopharmaceutical, Biomaterial)6.2.6. By Technique (Microfracture, Mosaicplasty)6.2.7. By Distribution Channel (Hospitals, Clinics, Online, Others)6.2.8. By Region6.2.9. By Company

7. North America Regenerative Medicine Market Outlook

8. Europe Regenerative Medicine Market Outlook

9. Asia-Pacific Regenerative Medicine Market Outlook

10. Middle East & Africa Printing Ink Market Outlook

11. South America Regenerative Medicine Market Outlook

12. Market Dynamics12.1. Drivers12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape14.1. Competition Outlook14.2. Company Profiles14.2.1. Novartis AG14.2.2. Vericel14.2.3. Integra Lifesciences14.2.4. Mimedx Group14.2.5. Stryker14.2.6. Wright Medical14.2.7. Roche14.2.8. Bristol-Myers Squibb14.2.9. Allergan14.2.10. Corline Biomedical14.2.11. Cook Biotech14.2.12. Pfizer14.2.13. Baxter14.2.14. Boehringer Ingelheim14.2.15. Caladrius Biosciences14.2.16. Takara Bio14.2.17. Medtronic14.2.18. Osiris Therapeutics14.2.19. Kite Pharma14.2.20. Organogenesis

15. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/2zlobm

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/regenerative-medicine-industry-outlook-to-2025-featuring-novartis-vericel-integra-lifesciences-mimedx-group-stryker-wright-medical-roche-and-more-301059297.html

SOURCE Research and Markets

See the original post here:
Regenerative Medicine Industry Outlook to 2025 Featuring Novartis, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche and...